Research ID
hum0531-v1Release info
Research title
Identification of Therapeutic Target Molecules in Urological Tumors by Whole-Genome Sequencing
Research overview
- Aims
- Urological malignancies, including prostate, kidney, and bladder cancers, are increasing, with somatic genomic alterations playing a key role. Traditional analyses are insufficient to fully explain tumorigenesis. Using next-generation sequencing, this study aims to comprehensively identify tumor-specific alterations and novel therapeutic targets through multi-layered genomic analysis.
- Methods
- Targeted panel analysis using the NOIR-SS method was performed on formalin-fixed paraffin-embedded (FFPE) tumor tissues from 15 patients with advanced urothelial carcinoma and identified somatic mutations. Plasma cfDNA (50 samples) from the same patients was analyzed using a tumor-informed approach, focusing on the mutations identified in the corresponding tumor tissues.
- Participants/materials
- Advanced urothelial carcinoma 15 cases
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000978 | NGS (Amplicon-seq) |
| Controlled-access (Type I) | 2025-11-12 |
Data provider
- Principal investigator
- Yoichi Fujii
- Affiliation
- Department of Urology, The University of Tokyo Graduate School of Medicine
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Scientific Research (C) | Quantification of ctDNA and Identification of Background Factors in Clear Cell Renal Cell Carcinoma Using NOIR-SS |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
High Sensitivity ctDNA Analysis Using a Novel Panel and NOIR-SS Technology for Monitoring Advanced Urothelial Carcinoma |
Controlled access users
No use of the controlled access data has been recorded.